Sialogogic activities of SNI-2011 compared with those of pilocarpine and McN-A-343 in rat salivary glands: identification of a potential therapeutic agent for treatment of Sjörgen's syndrome.

[1]  Iwabuchi Yoshiki,et al.  Effects of cholinergic and adrenergic agonists on the secretion of fluid and protein by submandibular glands of the hamster and the rat. , 1992 .

[2]  T. Masuhara,et al.  Subtypes of the muscarine receptors that are involved in pilocarpine-induced secretion of saliva from rat sublingual glands , 1992 .

[3]  Y. Iwabuchi,et al.  Subtype of the muscarinic receptor that mediates salivary secretion in the rat sublingual gland , 1992 .

[4]  N. Fleming,et al.  Muscarinic M3 receptors are coupled to two signal transduction pathways in rat submandibular cells. , 1990, European journal of pharmacology.

[5]  S. Lazareno,et al.  Functional and binding studies with muscarinic M2‐subtype selective antagonists , 1989, British journal of pharmacology.

[6]  A. Michel,et al.  Direct labeling of rat M3-muscarinic receptors by [3H]4DAMP. , 1989, European journal of pharmacology.

[7]  A. Fisher,et al.  (±)-cis-2-Methyl-spiro(1,3-oxathiolane-5,3′) quinuclidine (AF102B): A new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats , 1989, Neuroscience Letters.

[8]  A. Michel,et al.  Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites , 1989, British journal of pharmacology.

[9]  Y. Iga,et al.  Beneficial effects of FKS-508 (AF102B), a selective M1 agonist, on the impaired working memory in AF64A-treated rats. , 1989, Japanese journal of pharmacology.

[10]  A. Fisher,et al.  Dual synaptic effects of activating M1-muscarinic receptors, in superior cervical ganglia of rabbits , 1988, Brain Research.

[11]  T. Masuhara,et al.  A comparative study of the effects of four choline esters on the secretion of fluid and glycoprotein from rat submandibular glands. , 1988, Japanese journal of pharmacology.

[12]  P. V. van Zwieten,et al.  Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors. , 1987, The Journal of pharmacology and experimental therapeutics.

[13]  R. Eglen,et al.  Muscarinic activity of McN‐A‐343 and its value in muscarinic receptor classification , 1987, British journal of pharmacology.

[14]  A. Giachetti,et al.  Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist. , 1986, Life sciences.

[15]  H. Ladinsky,et al.  Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat. , 1986, Life sciences.

[16]  J. Putney,et al.  A model for receptor-regulated calcium entry. , 1986, Cell calcium.

[17]  J. Putney,et al.  Identification of cellular activation mechanisms associated with salivary secretion. , 1986, Annual review of physiology.

[18]  R. Eglen,et al.  Action of agonists and antagonists at muscarinic receptors present on ileum and atria in vitro , 1985, British journal of pharmacology.

[19]  P. Timmermans,et al.  Role of ganglionic M-1 and M-2 receptors in the neuronal control of the cardiovascular system of the normotensive rat as determined with pilocarpine. , 1983, European journal of pharmacology.

[20]  H. Yamamura,et al.  A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes. , 1983, Life sciences.

[21]  N. Birdsall,et al.  Muscarinic receptor subclasses , 1983 .

[22]  R. Hammer,et al.  Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. , 1982, Life sciences.

[23]  J. Garthwaite,et al.  MUSCARINIC RECEPTORS IN RAT SYMPATHETIC GANGLIA , 1980, British journal of pharmacology.

[24]  N. Birdsall,et al.  Pirenzepine distinguishes between different subclasses of muscarinic receptors , 1980, Nature.

[25]  P. Glenton,et al.  A COMPARISON OF AFFINITY CONSTANTS FOR MUSCARINE‐SENSITIVE ACETYLCHOLINE RECEPTORS IN GUINEA‐PIG ATRIAL PACEMAKER CELLS AT 29°C AND IN ILEUM AT 29°C AND 37°C , 1976, British journal of pharmacology.

[26]  Mandel Id,et al.  Effect of pilocarpine and a beta adrenergic blocking agent on human saliva. , 1971 .

[27]  C. Schneyer,et al.  Role of β-Receptors in Sympathetic Regulation of Electrolytes in Rat Submaxillary Saliva.∗ , 1967 .

[28]  C. Dawes.  The composition of human saliva secreted in response to a gustatory stimulus and to pilocarpine , 1966 .

[29]  C. Schneyer,et al.  Autonomic Pathways Involved in a Sympathetic-Like Action of Pilocarpine on Salivary Composition.∗ , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[30]  K. Unna,et al.  STIMULANT ACTION OF 4-(m-CHLOROPHENYLCARBAMOYLOXY)-2-BUTYNYLTRIMETHYLAMMONIUM CHLORIDE (McN-A-343) ON SYMPATHETIC GANGLIA , 1963 .

[31]  J. Hurkmans,et al.  Classification and molecular pharmacology of ganglionic blocking agents Part I , 1962 .

[32]  A. Roszkowski.  An unusual type of sympathetic ganglionic stimulant. , 1961, The Journal of pharmacology and experimental therapeutics.